GEN vs NRIX · P/E 17, rev $5.00B vs rev $54.5M
Gen Digital Inc. (GEN) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Gen Digital Inc. (GEN) is a software - infrastructure company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported GEN revenue for 2026-04-03 was $5.00B. Net income was $973.0M. Revenue was up 27.1% from 2025-03-28 to 2026-04-03. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
GEN currently screens at market cap $15.83B and trailing P/E 16.7. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the GEN and NRIX stock pages for the full models.
Not investment advice.